Status:
COMPLETED
A Prospective Randomized Study Evaluating the Recurrence Rate of Chronic Subdural Hematoma After Placing a Subperiosteal Drainage Compared to a Subdural Drainage
Lead Sponsor:
Kantonsspital Aarau
Conditions:
Chronic Subdural Hematoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of our study is to investigate in randomized controlled fashion whether the recurrence and complication rate, after insertion of subperiosteal drainage in the treatment of chronic subdural hae...
Detailed Description
Chronic subdural haematoma (cSDH) is one of the most frequent neurosurgical entities, affecting elderly people and associated with substantial morbidity and mortality. Its incidence is reported to be ...
Eligibility Criteria
Inclusion
- Patient at least 18 years of age presenting with a symptomatic chronic subdural hematoma
- Chronic subdural hematoma verified on cranial CT or MRI
Exclusion
- The surgeon decides based on intraoperative conditions to perform a craniotomy (e.g. acute hematoma indicating a craniotomy)
- Chronic subdural hematoma caused by another underlying illness (e.g. caused by over-drainage of a vp-shunt)
- no informed consent
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01869855
Start Date
April 1 2013
End Date
January 1 2017
Last Update
June 27 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurosurgery Kantonsspital Aarau
Aarau, Canton of Aargau, Switzerland, 5000
2
Neurosurgery University Hospital of Basel
Basel, Switzerland, 4038